Replimune Group Stock Price History
| REPL Stock | USD 12.09 0.41 3.28% |
Below is the normalized historical share price chart for Replimune Group extending back to July 20, 2018. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Replimune stands at 12.09, as last reported on the 20th of July, with the highest price reaching 12.78 and the lowest price hitting 11.62 during the day.
If you're considering investing in Replimune Stock, it is important to understand the factors that can impact its price. Replimune appears to be somewhat reliable, given 3 months investment horizon. Replimune Group maintains Sharpe Ratio (i.e., Efficiency) of 0.12, which implies the firm had a 0.12 % return per unit of risk over the last 3 months. By analyzing Replimune's technical indicators, you can evaluate if the expected return of 0.66% is justified by implied risk. Please evaluate Replimune's Risk Adjusted Performance of 0.1602, coefficient of variation of 614.54, and Semi Deviation of 4.89 to confirm if our risk estimates are consistent with your expectations.
Other Stockholder Equity is expected to rise to about 1.4 B this year, although the value of Total Stockholder Equity will most likely fall to about 310.2 M. . At this time, Replimune's Price Book Value Ratio is quite stable compared to the past year. Price Earnings To Growth Ratio is expected to rise to 0.64 this year, although the value of Price To Operating Cash Flows Ratio will most likely fall to (2.62). Replimune Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 20th of July 2018 | 200 Day MA 11.0613 | 50 Day MA 9.4332 | Beta 0.612 |
Replimune | Build AI portfolio with Replimune Stock |
Sharpe Ratio = 0.1234
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | REPL | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 5.34 actual daily | 47 53% of assets are more volatile |
Expected Return
| 0.66 actual daily | 13 87% of assets have higher returns |
Risk-Adjusted Return
| 0.12 actual daily | 9 91% of assets perform better |
Based on monthly moving average Replimune is performing at about 9% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Replimune by adding it to a well-diversified portfolio.
Replimune Stock Price History Chart
There are several ways to analyze Replimune Stock price data. The simplest method is using a basic Replimune candlestick price chart, which shows Replimune price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | July 16, 2025 | 12.63 |
| Lowest Price | May 14, 2025 | 7.01 |
Replimune July 20, 2025 Stock Price Synopsis
Various analyses of Replimune's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Replimune Stock. It can be used to describe the percentage change in the price of Replimune from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Replimune Stock.| Replimune Price Action Indicator | (0.31) | |
| Replimune Price Daily Balance Of Power | (0.35) | |
| Replimune Price Rate Of Daily Change | 0.97 |
Replimune July 20, 2025 Stock Price Analysis
Replimune Stock Price History Data
The price series of Replimune for the period between Mon, Apr 21, 2025 and Sun, Jul 20, 2025 has a statistical range of 5.62 with a coefficient of variation of 13.42. The price distribution for the period has arithmetic mean of 9.28. The median price for the last 90 days is 9.37.| Open | High | Low | Close | Volume | ||
07/20/2025 | 12.63 | 12.78 | 11.62 | 12.09 | ||
| 07/18/2025 | 12.63 | 12.78 | 11.62 | 12.09 | 3,350,467 | |
07/17/2025 | 12.81 | 12.85 | 12.35 | 12.50 | 2,963,655 | |
07/16/2025 | 13.19 | 13.19 | 12.03 | 12.63 | 4,101,705 | |
| 07/15/2025 | 11.47 | 12.43 | 11.24 | 12.40 | 4,903,043 | |
07/14/2025 | 10.94 | 11.41 | 10.83 | 11.28 | 2,078,460 | |
| 07/11/2025 | 10.85 | 11.29 | 10.65 | 10.97 | 2,300,217 | |
07/10/2025 | 10.50 | 10.84 | 10.20 | 10.77 | 2,269,580 | |
07/09/2025 | 9.47 | 10.41 | 9.40 | 10.39 | 2,338,826 | |
07/08/2025 | 9.64 | 9.89 | 9.26 | 9.34 | 1,288,021 | |
07/07/2025 | 9.51 | 9.90 | 9.37 | 9.65 | 1,741,132 | |
| 07/03/2025 | 9.70 | 9.79 | 9.31 | 9.40 | 581,094 | |
07/02/2025 | 9.15 | 9.70 | 9.15 | 9.55 | 1,375,757 | |
07/01/2025 | 9.27 | 9.73 | 9.12 | 9.15 | 1,675,847 | |
06/30/2025 | 9.45 | 9.64 | 9.15 | 9.29 | 1,251,947 | |
06/27/2025 | 9.48 | 9.57 | 9.16 | 9.33 | 1,400,154 | |
06/26/2025 | 9.53 | 9.78 | 9.23 | 9.46 | 1,523,969 | |
06/25/2025 | 9.87 | 9.93 | 9.35 | 9.45 | 1,268,966 | |
06/24/2025 | 9.44 | 9.83 | 8.92 | 9.75 | 1,457,790 | |
06/23/2025 | 9.16 | 9.38 | 9.08 | 9.23 | 794,173 | |
| 06/20/2025 | 9.64 | 9.64 | 9.17 | 9.27 | 1,468,600 | |
06/18/2025 | 9.47 | 9.70 | 9.26 | 9.49 | 850,702 | |
06/17/2025 | 9.75 | 10.09 | 9.50 | 9.51 | 859,781 | |
| 06/16/2025 | 9.89 | 10.00 | 9.68 | 9.83 | 741,381 | |
06/13/2025 | 9.66 | 9.94 | 9.65 | 9.78 | 680,239 | |
06/12/2025 | 9.62 | 10.11 | 9.50 | 9.89 | 1,053,989 | |
06/11/2025 | 10.14 | 10.24 | 9.55 | 9.78 | 1,207,825 | |
06/10/2025 | 10.19 | 10.50 | 10.09 | 10.13 | 721,277 | |
06/09/2025 | 10.60 | 10.75 | 10.05 | 10.18 | 791,029 | |
| 06/06/2025 | 9.83 | 10.41 | 9.77 | 10.38 | 1,927,195 | |
06/05/2025 | 9.63 | 10.01 | 9.34 | 9.75 | 798,754 | |
06/04/2025 | 10.06 | 10.38 | 9.57 | 9.69 | 1,033,166 | |
06/03/2025 | 9.65 | 9.90 | 9.11 | 9.63 | 1,491,923 | |
| 06/02/2025 | 9.28 | 10.16 | 9.21 | 9.57 | 2,316,580 | |
05/30/2025 | 9.29 | 9.35 | 8.61 | 8.98 | 2,181,169 | |
| 05/29/2025 | 8.61 | 9.53 | 8.30 | 9.37 | 2,424,705 | |
05/28/2025 | 8.41 | 8.77 | 8.25 | 8.43 | 1,089,288 | |
05/27/2025 | 8.78 | 8.91 | 8.35 | 8.42 | 1,118,290 | |
05/23/2025 | 8.71 | 8.74 | 7.81 | 8.35 | 1,461,136 | |
| 05/22/2025 | 8.80 | 9.85 | 8.21 | 8.76 | 2,688,455 | |
05/21/2025 | 9.25 | 9.75 | 8.26 | 8.46 | 2,895,257 | |
| 05/20/2025 | 8.19 | 9.28 | 8.19 | 9.19 | 2,054,457 | |
05/19/2025 | 7.76 | 8.30 | 7.48 | 8.20 | 1,029,832 | |
05/16/2025 | 7.21 | 8.32 | 7.21 | 7.85 | 1,688,491 | |
05/15/2025 | 7.08 | 7.32 | 6.84 | 7.23 | 692,930 | |
05/14/2025 | 7.41 | 7.46 | 6.89 | 7.01 | 763,752 | |
05/13/2025 | 7.87 | 7.95 | 7.40 | 7.41 | 663,397 | |
05/12/2025 | 7.87 | 8.28 | 7.67 | 7.86 | 764,794 | |
05/09/2025 | 7.77 | 8.54 | 7.63 | 7.71 | 1,369,958 | |
05/08/2025 | 7.19 | 8.06 | 6.93 | 7.77 | 1,094,938 | |
05/07/2025 | 7.73 | 7.77 | 7.00 | 7.16 | 2,247,527 | |
05/06/2025 | 9.85 | 9.96 | 7.47 | 7.50 | 4,051,201 | |
05/05/2025 | 10.00 | 10.30 | 9.75 | 10.01 | 655,093 | |
05/02/2025 | 9.73 | 10.21 | 9.72 | 10.01 | 724,313 | |
05/01/2025 | 9.83 | 9.84 | 9.49 | 9.64 | 651,530 | |
04/30/2025 | 9.25 | 9.85 | 9.20 | 9.78 | 882,812 | |
04/29/2025 | 9.22 | 9.55 | 9.01 | 9.39 | 529,745 | |
04/28/2025 | 9.11 | 9.31 | 9.02 | 9.27 | 1,895,292 | |
04/25/2025 | 8.90 | 9.19 | 8.68 | 9.05 | 362,638 | |
04/24/2025 | 8.82 | 9.20 | 8.77 | 9.06 | 443,601 | |
04/23/2025 | 8.96 | 9.34 | 8.82 | 8.83 | 674,883 |
About Replimune Stock history
Replimune investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Replimune is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Replimune Group will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Replimune stock prices may prove useful in developing a viable investing in Replimune
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 80.6 M | 51.7 M | |
| Net Loss | -106.2 M | -100.9 M |
Replimune Quarterly Net Working Capital |
|
Replimune Stock Technical Analysis
Replimune technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run USA ETFs Now
USA ETFsFind actively traded Exchange Traded Funds (ETF) in USA |
| All Next | Launch Module |
Replimune Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Replimune's price direction in advance. Along with the technical and fundamental analysis of Replimune Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Replimune to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1602 | |||
| Jensen Alpha | 0.7471 | |||
| Total Risk Alpha | 0.1118 | |||
| Sortino Ratio | 0.1276 | |||
| Treynor Ratio | 0.9712 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Replimune Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Replimune. If investors know Replimune will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Replimune listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Replimune Group is measured differently than its book value, which is the value of Replimune that is recorded on the company's balance sheet. Investors also form their own opinion of Replimune's value that differs from its market value or its book value, called intrinsic value, which is Replimune's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Replimune's market value can be influenced by many factors that don't directly affect Replimune's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Replimune's value and its price as these two are different measures arrived at by different means. Investors typically determine if Replimune is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Replimune's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.